Trade Core Laboratories - CLBus CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.17 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Core Laboratories NV ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Prev. Close* | 23.25 |
Open* | 23.12 |
1-Year Change* | 71.51% |
Day's Range* | 23.03 - 23.48 |
52 wk Range | 13.19-31.42 |
Average Volume (10 days) | 358.37K |
Average Volume (3 months) | 7.50M |
Market Cap | 1.05B |
P/E Ratio | 44.53 |
Shares Outstanding | 46.66M |
Revenue | 502.79M |
EPS | 0.51 |
Dividend (Yield %) | 0.1777 |
Beta | 2.67 |
Next Earnings Date | Jul 25, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Oct 2, 2023 | 23.25 | -0.20 | -0.85% | 23.45 | 23.59 | 22.67 |
Sep 29, 2023 | 23.84 | -0.20 | -0.83% | 24.04 | 24.45 | 23.80 |
Sep 28, 2023 | 24.47 | -0.10 | -0.41% | 24.57 | 25.07 | 24.12 |
Sep 27, 2023 | 24.87 | 0.93 | 3.88% | 23.94 | 24.87 | 23.68 |
Sep 26, 2023 | 23.33 | -0.46 | -1.93% | 23.79 | 24.09 | 23.17 |
Sep 25, 2023 | 23.92 | -0.06 | -0.25% | 23.98 | 24.05 | 23.37 |
Sep 22, 2023 | 24.03 | 0.22 | 0.92% | 23.81 | 24.39 | 23.79 |
Sep 21, 2023 | 23.74 | -0.56 | -2.30% | 24.30 | 24.62 | 23.57 |
Sep 20, 2023 | 24.18 | 0.78 | 3.33% | 23.40 | 24.50 | 23.37 |
Sep 19, 2023 | 23.64 | -0.69 | -2.84% | 24.33 | 24.34 | 23.25 |
Sep 18, 2023 | 24.23 | -0.15 | -0.62% | 24.38 | 24.72 | 23.84 |
Sep 15, 2023 | 24.78 | 0.78 | 3.25% | 24.00 | 25.07 | 23.93 |
Sep 14, 2023 | 24.74 | 0.39 | 1.60% | 24.35 | 24.76 | 24.05 |
Sep 13, 2023 | 24.23 | -1.34 | -5.24% | 25.57 | 25.57 | 23.82 |
Sep 12, 2023 | 25.49 | -0.01 | -0.04% | 25.50 | 26.37 | 25.04 |
Sep 11, 2023 | 25.29 | -0.48 | -1.86% | 25.77 | 25.91 | 25.14 |
Sep 8, 2023 | 25.65 | -0.39 | -1.50% | 26.04 | 26.34 | 25.54 |
Sep 7, 2023 | 26.04 | 0.69 | 2.72% | 25.35 | 26.24 | 25.35 |
Sep 6, 2023 | 25.49 | 1.48 | 6.16% | 24.01 | 25.54 | 24.01 |
Sep 5, 2023 | 24.33 | -0.31 | -1.26% | 24.64 | 25.30 | 24.30 |
Core Laboratories Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 489.735 | 470.252 | 487.267 | 668.21 | 700.846 |
Revenue | 489.735 | 470.252 | 487.267 | 668.21 | 700.846 |
Cost of Revenue, Total | 393.655 | 367.896 | 374.767 | 495.579 | 496.964 |
Gross Profit | 96.08 | 102.356 | 112.5 | 172.631 | 203.882 |
Total Operating Expense | 448.211 | 424.99 | 564.072 | 571.526 | 582.224 |
Selling/General/Admin. Expenses, Total | 38.117 | 44.173 | 34.033 | 48.023 | 62.91 |
Depreciation / Amortization | 17.161 | 18.516 | 20.867 | 22.605 | 23.087 |
Interest Expense (Income) - Net Operating | 0.229 | -0.228 | 1.16 | 1.725 | 2.598 |
Unusual Expense (Income) | 2.264 | -1.439 | 135.268 | -1.737 | -0.455 |
Other Operating Expenses, Total | -3.215 | -3.928 | -2.023 | 5.331 | -2.88 |
Operating Income | 41.524 | 45.262 | -76.805 | 96.684 | 118.622 |
Interest Income (Expense), Net Non-Operating | -11.57 | -9.152 | -14.372 | -14.69 | -13.328 |
Net Income Before Taxes | 29.954 | 36.11 | -91.177 | 81.994 | 105.294 |
Net Income After Taxes | 19.658 | 20.219 | -97.073 | 94.284 | 79.847 |
Minority Interest | -0.205 | -0.492 | -0.14 | -0.134 | -0.263 |
Net Income Before Extra. Items | 19.453 | 19.727 | -97.213 | 94.15 | 79.584 |
Total Extraordinary Items | 0 | 0 | -0.424 | 7.833 | -0.058 |
Net Income | 19.453 | 19.727 | -97.637 | 101.983 | 79.526 |
Income Available to Common Excl. Extra. Items | 19.453 | 19.727 | -97.213 | 94.15 | 79.584 |
Income Available to Common Incl. Extra. Items | 19.453 | 19.727 | -97.637 | 101.983 | 79.526 |
Diluted Net Income | 19.453 | 19.727 | -97.637 | 101.983 | 79.526 |
Diluted Weighted Average Shares | 46.813 | 46.69 | 44.477 | 44.646 | 44.474 |
Diluted EPS Excluding Extraordinary Items | 0.41555 | 0.42251 | -2.18569 | 2.10881 | 1.78945 |
Dividends per Share - Common Stock Primary Issue | 0.04 | 0.04 | 0.28 | 2.2 | 2.2 |
Diluted Normalized EPS | 0.44729 | 0.40525 | -0.20885 | 2.08352 | 1.78169 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total revenue | 128.356 | 127.571 | 125.966 | 120.898 | 115.3 |
Revenue | 128.356 | 127.571 | 125.966 | 120.898 | 115.3 |
Cost of Revenue, Total | 101.528 | 99.816 | 98.93 | 97.957 | 96.952 |
Gross Profit | 26.828 | 27.755 | 27.036 | 22.941 | 18.348 |
Total Operating Expense | 121.875 | 111.953 | 111.321 | 109.246 | 115.691 |
Selling/General/Admin. Expenses, Total | 16.331 | 8.724 | 10.001 | 6.847 | 12.545 |
Depreciation / Amortization | 4.044 | 4.073 | 4.171 | 4.36 | 4.557 |
Interest Expense (Income) - Net Operating | -0.144 | 0.691 | -1.303 | 1.258 | -0.417 |
Unusual Expense (Income) | 1.752 | -0.705 | -0.096 | -0.111 | 3.175 |
Other Operating Expenses, Total | -1.636 | -0.646 | -0.382 | -1.065 | -1.121 |
Operating Income | 6.481 | 15.618 | 14.645 | 11.652 | -0.391 |
Interest Income (Expense), Net Non-Operating | -3.429 | -3.081 | -3.138 | -2.707 | -2.644 |
Net Income Before Taxes | 3.052 | 12.537 | 11.507 | 8.945 | -3.035 |
Net Income After Taxes | 2.442 | 6.69 | 7.651 | 7.156 | -1.839 |
Minority Interest | -0.069 | 0.061 | -0.127 | -0.09 | -0.049 |
Net Income Before Extra. Items | 2.373 | 6.751 | 7.524 | 7.066 | -1.888 |
Total Extraordinary Items | 0 | ||||
Net Income | 2.373 | 6.751 | 7.524 | 7.066 | -1.888 |
Income Available to Common Excl. Extra. Items | 2.373 | 6.751 | 7.524 | 7.066 | -1.888 |
Income Available to Common Incl. Extra. Items | 2.373 | 6.751 | 7.524 | 7.066 | -1.888 |
Diluted Net Income | 2.373 | 6.751 | 7.524 | 7.066 | -1.888 |
Diluted Weighted Average Shares | 47.481 | 46.379 | 47.012 | 47.143 | 46.298 |
Diluted EPS Excluding Extraordinary Items | 0.04998 | 0.14556 | 0.16004 | 0.14988 | -0.04078 |
Dividends per Share - Common Stock Primary Issue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Diluted Normalized EPS | 0.0795 | 0.13745 | 0.15869 | 0.148 | 0.0038 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 211.702 | 189.055 | 165.848 | 221.237 | 230.977 |
Cash and Short Term Investments | 15.428 | 17.703 | 13.806 | 11.092 | 13.116 |
Cash & Equivalents | 15.428 | 17.703 | 13.806 | 11.092 | 13.116 |
Total Receivables, Net | 115.103 | 106.741 | 92.867 | 138.106 | 143.15 |
Accounts Receivable - Trade, Net | 106.913 | 96.83 | 83.192 | 131.579 | 129.157 |
Total Inventory | 60.445 | 45.443 | 38.151 | 50.163 | 45.664 |
Prepaid Expenses | 15.665 | 14.059 | 14.797 | 15.951 | 15.351 |
Other Current Assets, Total | 5.061 | 5.109 | 6.227 | 5.925 | 13.696 |
Total Assets | 578.354 | 580.853 | 568.579 | 774.673 | 648.827 |
Property/Plant/Equipment, Total - Net | 157.407 | 172.339 | 181.678 | 199.203 | 122.917 |
Property/Plant/Equipment, Total - Gross | 472.144 | 478.8 | 475.656 | 481.39 | 400.174 |
Accumulated Depreciation, Total | -314.737 | -306.461 | -293.978 | -282.187 | -277.257 |
Goodwill, Net | 99.445 | 99.445 | 99.445 | 213.425 | 219.412 |
Intangibles, Net | 7.483 | 8.139 | 8.583 | 17.45 | 13.054 |
Long Term Investments | 3.76 | ||||
Other Long Term Assets, Total | 102.317 | 111.875 | 113.025 | 123.358 | 58.707 |
Total Current Liabilities | 103.135 | 90.782 | 89.75 | 111.594 | 102.547 |
Accounts Payable | 45.847 | 29.726 | 23.028 | 35.611 | 41.155 |
Accrued Expenses | 39.952 | 39.106 | 44.519 | 46.896 | 30.037 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 17.336 | 21.95 | 22.203 | 29.087 | 31.355 |
Total Liabilities | 394.096 | 424.404 | 497.066 | 596.808 | 492.068 |
Total Long Term Debt | 172.386 | 188.636 | 259.433 | 305.283 | 289.77 |
Long Term Debt | 172.386 | 188.636 | 259.433 | 305.283 | 289.77 |
Deferred Income Tax | 22.877 | 24.336 | 20.585 | 26.284 | 7.634 |
Minority Interest | 4.696 | 4.552 | 4.06 | 4.275 | 4.141 |
Other Liabilities, Total | 91.002 | 116.098 | 123.238 | 149.372 | 87.976 |
Total Equity | 184.258 | 156.449 | 71.513 | 177.865 | 156.759 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
Common Stock | 1.194 | 1.188 | 1.148 | 1.148 | 1.148 |
Additional Paid-In Capital | 102.254 | 101.12 | 41.184 | 51.872 | 57.438 |
Retained Earnings (Accumulated Deficit) | 85.949 | 68.349 | 50.456 | 160.539 | 156.13 |
Treasury Stock - Common | -1.362 | -4.075 | -14.075 | -29.364 | -52.501 |
Unrealized Gain (Loss) | 1.331 | -4.538 | -1.825 | -5.64 | -6.243 |
Other Equity, Total | -5.108 | -5.595 | -5.375 | -0.69 | 0.787 |
Total Liabilities & Shareholders’ Equity | 578.354 | 580.853 | 568.579 | 774.673 | 648.827 |
Total Common Shares Outstanding | 46.6319 | 46.3494 | 44.5728 | 44.4656 | 44.3168 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 227.927 | 211.702 | 195.215 | 199.621 | 202.192 |
Cash and Short Term Investments | 16.285 | 15.428 | 13.732 | 16.148 | 22.037 |
Cash & Equivalents | 16.285 | 15.428 | 13.732 | 16.148 | 22.037 |
Total Receivables, Net | 124.48 | 115.103 | 109.493 | 111.499 | 113.54 |
Accounts Receivable - Trade, Net | 110.699 | 106.913 | 100.195 | 99.18 | 98.9 |
Total Inventory | 67.342 | 60.445 | 54.795 | 52.551 | 48.224 |
Prepaid Expenses | 13.197 | 15.665 | 11.514 | 14.252 | 13.611 |
Other Current Assets, Total | 6.623 | 5.061 | 5.681 | 5.171 | 4.78 |
Total Assets | 593.617 | 578.354 | 570.19 | 577.54 | 584.918 |
Property/Plant/Equipment, Total - Net | 159.004 | 157.407 | 163.841 | 167.14 | 170.094 |
Goodwill, Net | 99.445 | 99.445 | 99.445 | 99.445 | 99.445 |
Intangibles, Net | 7.268 | 7.483 | 7.651 | 7.837 | 7.979 |
Other Long Term Assets, Total | 99.973 | 102.317 | 104.038 | 103.497 | 105.208 |
Total Current Liabilities | 95.624 | 103.135 | 87.359 | 95.909 | 99.762 |
Accounts Payable | 38.366 | 45.847 | 34.343 | 36.106 | 34.405 |
Accrued Expenses | 38.247 | 39.952 | 37.323 | 42.291 | 43.929 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 19.011 | 17.336 | 15.693 | 17.512 | 21.428 |
Total Liabilities | 398.231 | 394.096 | 391.654 | 408.403 | 423.133 |
Total Long Term Debt | 180.44 | 172.386 | 182.677 | 186.979 | 189.807 |
Long Term Debt | 180.44 | 172.386 | 182.677 | 186.979 | 189.807 |
Deferred Income Tax | 22.268 | 22.877 | 22.719 | 23.322 | 23.27 |
Minority Interest | 4.765 | 4.696 | 4.757 | 4.63 | 4.601 |
Other Liabilities, Total | 95.134 | 91.002 | 94.142 | 97.563 | 105.693 |
Total Equity | 195.386 | 184.258 | 178.536 | 169.137 | 161.785 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
Common Stock | 1.194 | 1.194 | 1.188 | 1.188 | 1.188 |
Additional Paid-In Capital | 111.235 | 102.254 | 106.329 | 104.779 | 107.088 |
Retained Earnings (Accumulated Deficit) | 87.855 | 85.949 | 79.662 | 72.601 | 65.998 |
Treasury Stock - Common | -1.36 | -1.362 | -4.143 | -4.682 | -5.736 |
Unrealized Gain (Loss) | 1.541 | 1.331 | 1.095 | 0.846 | -1.158 |
Other Equity, Total | -5.079 | -5.108 | -5.595 | -5.595 | -5.595 |
Total Liabilities & Shareholders’ Equity | 593.617 | 578.354 | 570.19 | 577.54 | 584.918 |
Total Common Shares Outstanding | 46.634 | 46.6319 | 46.3447 | 46.3248 | 46.2837 |
Property/Plant/Equipment, Total - Gross | 417.368 | 419.765 | 420.352 | 418.98 | |
Accumulated Depreciation, Total | -315.027 | -314.737 | -313.1 | -309.804 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 19.658 | 20.219 | -97.073 | 94.284 | 79.847 |
Cash From Operating Activities | 24.956 | 36.579 | 57.868 | 89.527 | 111.827 |
Cash From Operating Activities | 17.161 | 18.516 | 20.867 | 22.605 | 23.087 |
Deferred Taxes | 0.433 | 6.012 | -12.216 | -36.345 | 1.832 |
Non-Cash Items | 12.723 | 12.395 | 140.351 | 16.69 | 36.052 |
Cash Taxes Paid | 14.078 | 9.066 | 21.325 | 13.804 | 31.928 |
Cash Interest Paid | 9.3 | 10.477 | 11.669 | 13.631 | 11.499 |
Changes in Working Capital | -25.019 | -20.563 | 5.939 | -7.707 | -28.991 |
Cash From Investing Activities | -3.856 | -10.223 | 7.851 | -5.677 | -70.639 |
Capital Expenditures | -10.216 | -13.539 | -11.88 | -22.269 | -22.931 |
Other Investing Cash Flow Items, Total | 6.36 | 3.316 | 19.731 | 16.592 | -47.708 |
Cash From Financing Activities | -23.375 | -22.459 | -63.005 | -85.874 | -42.472 |
Financing Cash Flow Items | -2.619 | -1.369 | -1.766 | 0.008 | -1.77 |
Total Cash Dividends Paid | -1.853 | -1.834 | -12.446 | -97.574 | -97.251 |
Issuance (Retirement) of Stock, Net | -3.903 | 51.744 | -2.793 | -3.308 | -7.451 |
Issuance (Retirement) of Debt, Net | -15 | -71 | -46 | 15 | 64 |
Net Change in Cash | -2.275 | 3.897 | 2.714 | -2.024 | -1.284 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 2.442 | 19.658 | 12.968 | 5.317 | -1.839 |
Cash From Operating Activities | -3.169 | 24.956 | 11.745 | 5.895 | 5.29 |
Cash From Operating Activities | 4.044 | 17.161 | 13.088 | 8.917 | 4.557 |
Deferred Taxes | 0.936 | 0.433 | -1.807 | 0.53 | 1.698 |
Non-Cash Items | 9.242 | 12.723 | 13.89 | 10.043 | 8.529 |
Cash Taxes Paid | 1.541 | 14.078 | 10.475 | 6.966 | 2.691 |
Cash Interest Paid | 2.956 | 9.3 | 7.101 | 4.359 | 2.508 |
Changes in Working Capital | -19.833 | -25.019 | -26.394 | -18.912 | -7.655 |
Cash From Investing Activities | -2.038 | -3.856 | -4.914 | -2.357 | 0.428 |
Capital Expenditures | -2.208 | -10.216 | -8.195 | -5.493 | -2.297 |
Other Investing Cash Flow Items, Total | 0.17 | 6.36 | 3.281 | 3.136 | 2.725 |
Cash From Financing Activities | 6.064 | -23.375 | -10.802 | -5.093 | -1.384 |
Financing Cash Flow Items | -1.469 | -2.619 | -2.102 | -0.001 | -0.001 |
Total Cash Dividends Paid | -0.466 | -1.853 | -1.389 | -0.926 | -0.463 |
Issuance (Retirement) of Stock, Net | -0.001 | -3.903 | -2.311 | -2.166 | -1.92 |
Issuance (Retirement) of Debt, Net | 8 | -15 | -5 | -2 | 1 |
Net Change in Cash | 0.857 | -2.275 | -3.971 | -1.555 | 4.334 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Core Laboratories Company profile
About Core Laboratories N.V.
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Core Laboratories N.V. revenues decreased 3% to $470.3M. Net income before extraordinary items totaled $19.7M vs. loss of $97.2M. Revenues reflect Reservoir Description segment decrease of 12% to $313.6M, United States segment decrease of 7% to $148.2M, Other Countries segment decrease of 2% to $322.1M. Net Income reflects Production Enhancement segment income totaling $15.2M vs. loss of $133.4M.
Equity composition
Common Stock EUR.02 Par 3/11, 200M auth., 49,739,912 issd., less 4,164,536 shs. in Treas. @ $261.4M. Insiders own 1.35%. IPO 9/95,2.8M shs @ $12 by Jefferies. PO 11/97, 300.8M. shs(1.4M by Co.) @ $36 by BTAB. 12/97, 2-for-1 stock split. FY'02-03 fincls. & '03 Qs are restated for discont. ops. 07/10, 2-for-1 stock split.
Industry: | Oil Related Services and Equipment (NEC) |
Van Heuven Goedhartlaan 7 B
1181 LE
Income Statement
- Annual
- Quarterly
News

How to Trade The Triple Top
Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.
14:13, 27 September 2023
Q4 lookahead: US indices starting to show signs of trouble?
US indices start to draw attention as traders focus on the outlook for Q4.
07:20, 27 September 2023
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com